Glück Conviction Score™ ⓘ
BEAM
Beam Therapeutics Inc.
Effektiv: Risiko-Ausstieg
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
54,8
53 neu, 90 erhöht, -149515K $ netto
Aktivist
21,4
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 29.56 | -1.8 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 26.68 | +8.8 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 29.93 | EMA50: 29.36 | |
| MACD-Histogramm | Bärisch | 10 % | -0.196 | Bearisch | |
| RSI(14) | Neutral | 10 % | 47.3 | Neutral (30–70) | |
| Stoch %K(14) | Bullisch | 5 % | 12.8 | Überverkauft | |
| ADX(14)+DI | Neutral | 10 % | 15.6 | +DI: 28.7 / −DI: 20.1 | |
| Z-Score(60) | Neutral | 5 % | 0.14 | In Range | |
| 52W-Position | Neutral | 5 % | 67.1 % | Hoch 35.41 / Tief 16.01 | |
| Bollinger(20,2σ) | Neutral | 5 % | 42.6 % | Upper 33.42 / Mid 29.60 / Lower 25.77 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.1090 | R²=0.40 / annualisiert +96.1 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Bellon Christine | Officer, Chief Legal Officer | Open Market Sale | -5.956 | 24,58 | -146.398,48 | -47,7% | |
| 2026-04-01 | Cavanagh Bethany J | Officer, SVP, Finance and Treasurer | Open Market Sale | -3.242 | 24,58 | -79.688,36 | -26,0% | |
| 2026-04-01 | Evans John M. | Director, Officer, CEO | Open Market Sale | -30.078 | 24,58 | -739.317,24 | -240,9% | |
| 2026-04-01 | Simon Amy | Officer, Chief Medical Officer | Open Market Sale | -6.700 | 24,58 | -164.686,00 | -53,7% | |
| 2026-04-01 | Ciaramella Giuseppe | Officer, President | Open Market Sale | -11.810 | 24,58 | -290.289,80 | -94,6% | |
| 2026-03-31 | Evans John M. | Director, Officer, CEO | Open Market Sale | -25.000 | 22,76 | -569.085,00 | -185,4% | |
| 2026-03-30 | Evans John M. | Director, Officer, CEO | Open Market Sale | -25.000 | 22,37 | -559.230,00 | -182,2% | |
| 2026-02-24 | Ciaramella Giuseppe | Officer, President | Open Market Sale | -35.000 | 32,00 | -1.120.042,00 | -364,9% | |
| 2026-01-30 | Evans John M. | Director, Officer, CEO | Open Market Sale | -22.094 | 28,27 | -624.672,50 | -203,5% | |
| 2026-01-30 | Evans John M. | Director, Officer, CEO | Open Market Sale | -2.906 | 29,00 | -84.274,00 | -27,5% | |
| 2026-01-29 | Evans John M. | Director, Officer, CEO | Open Market Sale | -16.333 | 29,19 | -476.801,10 | -155,4% | |
| 2026-01-29 | Evans John M. | Director, Officer, CEO | Open Market Sale | -8.667 | 29,74 | -257.780,85 | -84,0% | |
| 2026-01-22 | Cavanagh Bethany J | Officer, SVP, Finance and Treasurer | Open Market Sale | -6.198 | 35,00 | -216.933,10 | -70,7% | |
| 2026-01-22 | Bellon Christine | Officer, Chief Legal Officer | Open Market Sale | -1.371 | 34,00 | -46.614,00 | -15,2% | |
| 2026-01-20 | Cavanagh Bethany J | Officer, SVP, Finance and Treasurer | Open Market Sale | -3.034 | 30,12 | -91.384,08 | -29,8% | |
| 2026-01-15 | Bellon Christine | Officer, Chief Legal Officer | Open Market Sale | -15.959 | 34,72 | -554.067,75 | -180,5% | |
| 2026-01-15 | Bellon Christine | Officer, Chief Legal Officer | Open Market Sale | -2.111 | 33,62 | -70.975,83 | -23,1% | |
| 2026-01-15 | Bellon Christine | Officer, Chief Legal Officer | Open Market Sale | -559 | 35,40 | -19.787,93 | -6,4% | |
| 2025-12-31 | Emany Sravan Kumar | Officer, Chief Financial Officer | Open Market Sale | -6.294 | 27,10 | -170.567,40 | -55,6% | |
| 2025-12-31 | Bellon Christine | Officer, Chief Legal Officer | Open Market Sale | -1.254 | 27,10 | -33.983,40 | -11,1% | |
| 2025-10-27 | FMR LLC | 10% Owner | Open Market Sale | -459 | 26,68 | -12.246,12 | -4,0% | |
| 2025-10-02 | Evans John M. | Director, Officer, CEO | Open Market Sale | -25.000 | 24,63 | -615.667,50 | -200,6% | |
| 2025-10-01 | Evans John M. | Director, Officer, CEO | Open Market Sale | -25.000 | 24,51 | -612.655,00 | -199,6% | |
| 2025-10-01 | Bellon Christine | Officer, Chief Legal Officer | Open Market Sale | -373 | 24,53 | -9.149,69 | -3,0% | |
| 2025-10-01 | Cavanagh Bethany J | Officer, SVP, Finance and Treasurer | Open Market Sale | -467 | 24,53 | -11.455,51 | -3,7% | |
| 2025-07-30 | FMR LLC | 10% Owner | Open Market Sale | -48.374 | 20,50 | -991.667,00 | -323,1% | |
| 2025-07-03 | Simon Amy | Officer, Chief Medical Officer | Open Market Sale | -876 | 20,12 | -17.625,12 | -5,7% | |
| 2025-07-01 | Simon Amy | Officer, Chief Medical Officer | Open Market Sale | -374 | 16,94 | -6.336,42 | -2,1% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| FMR LLC | 12.452.199 | 11.909.138 | 543.061 | 296.735.900 | Aufgestockt | +4,6% | |
| ARK Investment Management LLC | 12.133.433 | 12.467.189 | -333.756 | 289.139.697 | Reduziert | -2,7% | |
| VANGUARD GROUP INC | 9.193.474 | 0 | 9.193.474 | 254.843.099 | Neu | +100,0% | |
| FARALLON CAPITAL MANAGEMENT LLC | 10.134.696 | 0 | 10.134.696 | 241.509.806 | Neu | +100,0% | |
| BlackRock, Inc. | 8.487.569 | 8.450.182 | 37.387 | 202.258.769 | Aufgestockt | +0,4% | |
| STATE STREET CORP | 5.699.265 | 5.228.529 | 470.736 | 135.813.485 | Aufgestockt | +9,0% | |
| ARCH Venture Management, LLC | 4.540.132 | 0 | 4.540.132 | 108.191.346 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.377.374 | 0 | 4.377.374 | 104.312.822 | Neu | +100,0% | |
| Amova Asset Management Americas, Inc. | 3.825.585 | 4.409.300 | -583.715 | 91.163.691 | Reduziert | -13,2% | |
| Sumitomo Mitsui Trust Group, Inc. | 3.825.585 | 4.409.300 | -583.715 | 91.163.691 | Reduziert | -13,2% | |
| Kynam Capital Management, LP | 3.682.185 | 3.377.214 | 304.971 | 87.746.469 | Aufgestockt | +9,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.418.592 | 2.351.908 | 66.684 | 57.647.252 | Aufgestockt | +2,8% | |
| DIMENSIONAL FUND ADVISORS LP | 2.154.575 | 1.947.879 | 206.696 | 51.326.975 | Aufgestockt | +10,6% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.653.714 | 1.712.359 | -58.645 | 39.408.002 | Reduziert | -3,4% | |
| MWG Caph Ltd | 1.266.934 | 0 | 1.266.934 | 35.119.410 | Neu | +100,0% | |
| ADAR1 Capital Management, LLC | 1.446.375 | 0 | 1.446.375 | 34.467.116 | Neu | +100,0% | |
| Casdin Capital, LLC | 1.350.000 | 1.600.000 | -250.000 | 32.170.500 | Reduziert | -15,6% | |
| Redmile Group, LLC | 1.237.659 | 1.285.859 | -48.200 | 29.493.414 | Reduziert | -3,7% | |
| TWO SIGMA INVESTMENTS, LP | 1.210.853 | 1.120.389 | 90.464 | 28.854.627 | Aufgestockt | +8,1% | |
| Woodline Partners LP | 993.066 | 0 | 993.066 | 27.527.790 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 1.084.768 | 399.659 | 685.109 | 25.850.021 | Aufgestockt | +171,4% | |
| GOLDMAN SACHS GROUP INC | 1.005.743 | 522.636 | 483.107 | 23.966.855 | Aufgestockt | +92,4% | |
| UBS Group AG | 826.061 | 973.843 | -147.782 | 19.685.034 | Reduziert | -15,2% | |
| NORTHERN TRUST CORP | 825.580 | 808.947 | 16.633 | 19.673.572 | Aufgestockt | +2,1% | |
| Deep Track Capital, LP | 820.765 | 0 | 820.765 | 19.558.830 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 808.436 | 834.795 | -26.359 | 19.265.030 | Reduziert | -3,2% | |
| CITADEL ADVISORS LLC | 806.070 | 508.810 | 297.260 | 19.208.648 | Aufgestockt | +58,4% | |
| JPMORGAN CHASE & CO | 619.241 | 0 | 619.241 | 17.165.361 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 700.647 | 468.910 | 231.737 | 16.696.418 | Aufgestockt | +49,4% | |
| MORGAN STANLEY | 648.264 | 729.400 | -81.136 | 15.448.144 | Reduziert | -11,1% | |
| TWO SIGMA ADVISERS, LP | 527.802 | 0 | 527.802 | 14.630.671 | Neu | +100,0% | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 492.430 | 0 | 492.430 | 13.650.160 | Neu | +100,0% | |
| RTW INVESTMENTS, LP | 570.394 | 570.394 | 0 | 13.592.489 | Unverändert | 0,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 556.591 | 722.211 | -165.620 | 13.263.564 | Reduziert | -22,9% | |
| BANK OF AMERICA CORP /DE/ | 538.290 | 427.328 | 110.962 | 12.827.450 | Aufgestockt | +26,0% | |
| Contrarius Group Holdings Ltd | 533.443 | 0 | 533.443 | 12.711.947 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 513.578 | 156.500 | 357.078 | 12.238.564 | Aufgestockt | +228,2% | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 488.417 | 533.563 | -45.146 | 11.638.977 | Reduziert | -8,5% | |
| Elmind Capital, LP | 476.338 | 476.338 | 0 | 11.351.135 | Unverändert | 0,0% | |
| BAILLIE GIFFORD & CO | 385.891 | 416.224 | -30.333 | 9.195.783 | Reduziert | -7,3% | |
| Alphabet Inc. | 321.604 | 321.604 | 0 | 7.663.823 | Unverändert | 0,0% | |
| Integral Health Asset Management, LLC | 300.000 | 550.000 | -250.000 | 7.149.000 | Reduziert | -45,5% | |
| Pictet Asset Management Holding SA | 297.504 | 325.654 | -28.150 | 6.544.133 | Reduziert | -8,6% | |
| PEREGRINE INVESTMENT MANAGEMENT INC | 260.050 | 257.280 | 2.770 | 6.196.992 | Aufgestockt | +1,1% | |
| Nuveen, LLC | 232.596 | 233.065 | -469 | 5.542.763 | Reduziert | -0,2% | |
| Man Group plc | 231.994 | 0 | 231.994 | 5.528.417 | Neu | +100,0% | |
| Invesco Ltd. | 219.961 | 213.185 | 6.776 | 5.241.671 | Aufgestockt | +3,2% | |
| ExodusPoint Capital Management, LP | 163.316 | 0 | 163.316 | 4.527.120 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 181.500 | 94.900 | 86.600 | 4.325.145 | Aufgestockt | +91,3% | |
| Swiss National Bank | 180.600 | 179.500 | 1.100 | 4.303.698 | Aufgestockt | +0,6% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| FMR LLC | 12.452.199 | 11.909.138 | +4,6% | 296.735.900 | 12,44 |
| ARK Investment Management LLC | 12.133.433 | 12.467.189 | -2,7% | 289.139.697 | 12,12 |
| FARALLON CAPITAL MANAGEMENT LLC | 10.134.696 | 0 | +100,0% | 241.509.806 | 10,12 |
| BlackRock, Inc. | 8.487.569 | 8.450.182 | +0,4% | 202.258.769 | 8,48 |
| STATE STREET CORP | 5.699.265 | 5.228.529 | +9,0% | 135.813.485 | 5,69 |
| ARCH Venture Management, LLC | 4.540.132 | 0 | +100,0% | 108.191.346 | 4,54 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.377.374 | 0 | +100,0% | 104.312.822 | 4,37 |
| Amova Asset Management Americas, Inc. | 3.825.585 | 4.409.300 | -13,2% | 91.163.691 | 3,82 |
| Sumitomo Mitsui Trust Group, Inc. | 3.825.585 | 4.409.300 | -13,2% | 91.163.691 | 3,82 |
| Kynam Capital Management, LP | 3.682.185 | 3.377.214 | +9,0% | 87.746.469 | 3,68 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.418.592 | 2.351.908 | +2,8% | 57.647.252 | 2,42 |
| DIMENSIONAL FUND ADVISORS LP | 2.154.575 | 1.947.879 | +10,6% | 51.326.975 | 2,15 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.653.714 | 1.712.359 | -3,4% | 39.408.002 | 1,65 |
| ADAR1 Capital Management, LLC | 1.446.375 | 0 | +100,0% | 34.467.116 | 1,44 |
| Casdin Capital, LLC | 1.350.000 | 1.600.000 | -15,6% | 32.170.500 | 1,35 |
| Redmile Group, LLC | 1.237.659 | 1.285.859 | -3,7% | 29.493.414 | 1,24 |
| TWO SIGMA INVESTMENTS, LP | 1.210.853 | 1.120.389 | +8,1% | 28.854.627 | 1,21 |
| Qube Research & Technologies Ltd | 1.084.768 | 399.659 | +171,4% | 25.850.021 | 1,08 |
| GOLDMAN SACHS GROUP INC | 1.005.743 | 522.636 | +92,4% | 23.966.855 | 1,00 |
| UBS Group AG | 826.061 | 973.843 | -15,2% | 19.685.034 | 0,83 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 252 | 113,5 | 2.626 |
| 31.12.2025 | ✓ | 241 | 105,9 | 2.849 |
| 30.09.2025 | ✓ | 221 | 116,0 | 2.750 |
| 30.06.2025 | ✓ | 213 | 113,4 | 1.856 |
| 31.03.2025 | ✓ | 231 | 100,4 | 1.905 |
| 31.12.2024 | ✓ | 228 | 78,6 | 1.893 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| MWG Caph Ltd | 1.266.934 | 35.119.410 |
| MARSHALL WACE, LLP | 945.829 | 26.218.379 |
| RTW INVESTMENTS, LP | 570.394 | 15.811.322 |
| Elmind Capital, LP | 476.338 | 13.204.089 |
| Liontrust Investment Partners LLP | 170.404 | 4.723.599 |
| ExodusPoint Capital Management, LP | 163.316 | 4.527.120 |
| RENAISSANCE TECHNOLOGIES LLC | 156.500 | 4.338.180 |
| Concurrent Investment Advisors, LLC | 76.825 | 2.129.589 |
| FIRST TRUST ADVISORS LP | 64.056 | 1.775.632 |
| Ishara Investments LP | 50.000 | 1.386.000 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| ARK Investment Management LLC | 12.467.189 | 1.428.355 | +12.9 % | 345.590.488 |
| STATE STREET CORP | 5.228.529 | 1.219.871 | +30.4 % | 144.934.824 |
| Kynam Capital Management, LP | 3.377.214 | 859.567 | +34.1 % | 93.616.372 |
| TWO SIGMA INVESTMENTS, LP | 1.120.389 | 741.345 | +195.6 % | 31.057.183 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.730.282 | 467.133 | +20.6 % | 75.684 |
| Caption Management, LLC | 710.852 | 448.352 | +170.8 % | 19.704.817 |
| Woodline Partners LP | 993.066 | 446.507 | +81.7 % | 27.527.790 |
| BNP PARIBAS FINANCIAL MARKETS | 468.910 | 444.940 | +1856.2 % | 12.998.185 |
| MILLENNIUM MANAGEMENT LLC | 451.650 | 421.900 | +1418.2 % | 12.519.738 |
| Qube Research & Technologies Ltd | 399.659 | 329.228 | +467.4 % | 11.078.547 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Bellevue Group AG | 111.510 | -2.777.778 | -96.1 % | 3.091.057 |
| GOLDMAN SACHS GROUP INC | 522.636 | -796.017 | -60.4 % | 14.487.470 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 492.430 | -767.581 | -60.9 % | 13.650.160 |
| Sumitomo Mitsui Trust Group, Inc. | 4.409.300 | -421.438 | -8.7 % | 122.225.796 |
| Amova Asset Management Americas, Inc. | 4.409.300 | -421.438 | -8.7 % | 122.181.703 |
| ROYAL BANK OF CANADA | 15.681 | -400.574 | -96.2 % | 435.000 |
| BANK OF AMERICA CORP /DE/ | 427.328 | -351.696 | -45.1 % | 11.845.532 |
| Schonfeld Strategic Advisors LLC | 128.360 | -167.730 | -56.6 % | 3.558.137 |
| UBS Group AG | 973.843 | -163.790 | -14.4 % | 26.994.928 |
| Redmile Group, LLC | 1.285.859 | -101.700 | -7.3 % | 35.644.011 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 29.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,02 % | 5.122.475 | Neu | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -8,79 pp | |
| 09.02.2026 | STATE STREET CORPORATION | Passiv (13G) | 5,20 % | 5.228.529 | +0,40 pp | |
| 05.02.2026 | Spokes, Andrew J. M. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Saito Edric C. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Short Daniel S. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Warren, John R. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Wehrly, Mark C. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Fried, Richard B | Passiv (13G/A) | Ausstieg | 0 | -9,99 pp | |
| 05.02.2026 | Patel, Rajiv A. | Passiv (13G/A) | Ausstieg | 0 | -9,99 pp | |
| 05.02.2026 | Farallon Healthcare Partners (GP), L.L.C. | Passiv (13G/A) | 6,00 % | 6.068.735 | +0,20 pp | |
| 05.02.2026 | Linn, Michael G. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Husen, Avner A. | Passiv (13G/A) | 9,99 % | 10.141.856 | Neu | |
| 05.02.2026 | Seybold, William | Passiv (13G/A) | Ausstieg | 0 | -9,99 pp | |
| 05.02.2026 | Farallon Capital (AM) Investors, L.P. | Passiv (13G/A) | 0,10 % | 94.237 | 0,00 pp | |
| 05.02.2026 | Farallon Healthcare Partners Master, L.P. | Passiv (13G/A) | 6,00 % | 6.068.735 | +0,20 pp | |
| 05.02.2026 | Luo Patrick (Cheng) | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Gehani, Varun N. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Farallon Capital Institutional Partners II, L.P. | Passiv (13G/A) | 0,20 % | 233.233 | 0,00 pp | |
| 05.02.2026 | Farallon Capital Partners, L.P. | Passiv (13G/A) | 0,70 % | 688.623 | 0,00 pp | |
| 05.02.2026 | Four Crossings Institutional Partners V, L.P. | Passiv (13G/A) | 0,10 % | 150.101 | -0,10 pp | |
| 05.02.2026 | Dreyfuss, Philip D. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Farallon Partners, L.L.C. | Passiv (13G/A) | 9,70 % | 9.808.603 | +0,10 pp | |
| 05.02.2026 | Farallon Capital F5 Master I, L.P. | Passiv (13G/A) | 0,30 % | 333.253 | 0,00 pp | |
| 05.02.2026 | Farallon Capital Offshore Investors II, L.P. | Passiv (13G/A) | 1,60 % | 1.632.718 | -0,10 pp | |
| 05.02.2026 | Farallon F5 (GP), L.L.C. | Passiv (13G/A) | 0,30 % | 333.253 | 0,00 pp | |
| 05.02.2026 | Giauque, Nicolas | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Farallon Capital Institutional Partners, L.P. | Passiv (13G/A) | 0,80 % | 836.691 | -0,10 pp | |
| 05.02.2026 | Kim, David T. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Dunn Hannah E. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Roberts, Jr., Thomas G. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Dapice Joshua J. | Passiv (13G/A) | 9,99 % | 10.141.856 | 0,00 pp | |
| 05.02.2026 | Farallon Capital Institutional Partners III, L.P. | Passiv (13G/A) | 0,10 % | 104.266 | 0,00 pp | |
| 05.02.2026 | Farallon Institutional (GP) V, L.L.C. | Passiv (13G/A) | 0,10 % | 150.101 | -0,10 pp | |
| 05.02.2026 | Abigail P. Johnson | Passiv (13G/A) | 12,60 % | 12.750.369 | -1,00 pp | |
| 05.02.2026 | FMR LLC | Passiv (13G/A) | 12,60 % | 12.750.369 | -1,00 pp | |
| 03.02.2026 | Catherine D. Wood | Passiv (13G/A) | 12,29 % | 12.467.189 | +1,94 pp | |
| 03.02.2026 | ARK Investment Management LLC | Passiv (13G/A) | 12,29 % | 12.467.189 | +1,94 pp | |
| 05.11.2025 | FMR LLC | Passiv (13G/A) | 13,60 % | 13.766.518 | -1,40 pp | |
| 05.11.2025 | Abigail P. Johnson | Passiv (13G/A) | 13,60 % | 13.766.518 | -1,40 pp |
Stammdaten
Beam Therapeutics Inc. ist ein Biotechnologie-Unternehmen, das Präzisions-Gentherapien für Patienten mit schweren Erkrankungen in den Vereinigten Staaten entwickelt. Das Unternehmen entwickelt BEAM-101 zur Behandlung von Sichelzellanämie und Beta-Thalassämie; BEAM-102 zur Behandlung von Sichelzellanämie; und BEAM-201, eine allogene chimäre Antigen-Rezeptor-T-Zelle zur Behandlung von rezidivierter/refraktärer T-Zell-akuter lymphoblastischer Leukämie; und BEAM-301, ein leberzielgerichteter Entwicklungskandidat zur Behandlung von Patienten mit Glykogenspeicherkrankheit Typ Ia. Es entwickelt auch Therapien für Alpha-1-Antitrypsin-Mangel, Augenerkrankungen und weitere Leber-, Muskel- und Zentralnervensystem-Erkrankungen. Das Unternehmen hat eine Allianz mit Boston Children's Hospital; eine Forschungs- und klinische Versuchszusammenarbeitsvereinbarung mit Magenta Therapeutics, Inc.; eine Lizenzvereinbarung mit Sana Biotechnology, Inc.; und eine Forschungszusammenarbeit mit dem Institut für Molekulare und Klinische Ophthalmologie Basel. Es hat auch eine Forschungszusammenarbeitsvereinbarung mit Pfizer Inc. und Apellis Pharmaceuticals, Inc.; sowie eine Zusammenarbeits- und Lizenzvereinbarung mit Verve Therapeutics, Inc. Das Unternehmen wurde 2017 gegründet und hat seinen Sitz in Cambridge, Massachusetts.
Unternehmen & Branche
| Name | Beam Therapeutics Inc. |
|---|---|
| Ticker | BEAM |
| CIK | 0001745999 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 07373V105 |
|---|---|
| ISIN | US07373V1052 |
| Typ | Common Stock |
| Marktkapitalisierung | 2,99 Mrd. USD |
| Beta | 2,23 |
Bewertung
| KBV (P/B) | 2,42 vs. 6,59 (2021) ▼ |
|---|---|
| KUV (P/S) | 21,41 vs. 105,12 (2021) ▼ |
| FCF-Rendite | -12,0 % vs. -2,1 % (2021) ▼ |
Qualität & Bilanz
| Operative Marge | -274,6 % vs. -757,0 % (2021) ▲ |
|---|---|
| Nettomarge | -57,2 % vs. -714,9 % (2021) ▲ |
| ROIC | -5,7 % vs. -38,0 % (2021) ▲ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 6,59 | 3,80 | 2,26 | 2,83 | 2,28 | |
| KUV (P/S) | 105,12 | 45,76 | 5,88 | 32,65 | 20,18 | |
| FCF-Rendite | -2,1 % | -0,9 % | -8,2 % | -17,2 % | -12,8 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | -757,0 % | -555,6 % | -46,7 % | -654,3 % | -274,6 % | |
| Nettomarge | -714,9 % | -474,5 % | -35,1 % | -593,1 % | -57,2 % | |
| ROIC | -38,0 % | -31,6 % | -11,5 % | -42,1 % | -5,7 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 31.738.000 | -94.318.000 | -0,91 | 1.480.798.000 | 1.164.438.000 |
| 2025-12-31 | 10-K | 139.743.000 | -79.992.000 | -0,81 | 1.481.177.000 | 1.238.358.000 |
| 2025-09-30 | 10-Q | 9.698.000 | -112.728.000 | -1,10 | 1.311.081.000 | 966.002.000 |
| 2025-06-30 | 10-Q | 8.466.000 | -102.291.000 | -1,00 | 1.391.157.000 | 1.046.813.000 |
| 2025-03-31 | 10-Q | 7.470.000 | -109.270.000 | -1,24 | 1.466.920.000 | 1.123.136.000 |
| 2024-12-31 | 10-K | 63.518.000 | -376.742.000 | -4,58 | 1.103.824.000 | 733.545.000 |
| 2024-09-30 | 10-Q | 14.269.000 | -96.668.000 | -1,17 | 1.171.367.000 | 791.317.000 |
| 2024-06-30 | 10-Q | 11.772.000 | -91.051.000 | -1,11 | 1.261.266.000 | 854.094.000 |
| 2024-03-31 | 10-Q | 7.410.000 | -98.669.000 | -1,21 | 1.359.796.000 | 913.490.000 |
| 2023-12-31 | 10-K | 377.709.000 | -132.527.000 | -1,72 | 1.459.714.000 | 981.329.000 |
| 2023-09-30 | 10-Q | 17.193.000 | -96.088.000 | -1,22 | 1.290.534.000 | 778.941.000 |
| 2023-06-30 | 10-Q | 20.116.000 | -82.776.000 | -1,08 | 1.353.887.000 | 811.643.000 |
| 2023-03-31 | 10-Q | 24.208.000 | -96.460.000 | -1,33 | 1.332.352.000 | 761.506.000 |
| 2022-12-31 | 10-K | 60.920.000 | -289.088.000 | -4,13 | 1.341.714.000 | 733.474.000 |
| 2022-09-30 | 10-Q | 15.799.000 | -109.575.000 | -1,56 | 1.350.250.000 | 714.477.000 |
| 2022-06-30 | 10-Q | 16.652.000 | -71.950.000 | -1,02 | 1.418.375.000 | 800.161.000 |
| 2022-03-31 | 10-Q | 8.432.000 | -69.214.000 | -1,01 | 1.453.402.000 | 829.068.000 |
| 2021-12-31 | 10-K | 51.844.000 | -370.638.000 | -5,77 | 1.474.453.000 | 826.738.000 |
| 2021-09-30 | 10-Q | 763.000 | -28.118.000 | -0,42 | 1.156.555.000 | 853.814.000 |
| 2021-06-30 | 10-Q | 6.000 | -76.253.000 | -1,23 | 893.078.000 | 548.551.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | 31,7 Mio. USD | -0,91 |
| Q3 2025 | 30.09.2025 | 04.11.2025 | 9,7 Mio. USD | -1,10 |
| Q2 2025 | 30.06.2025 | 04.11.2025 | 8,5 Mio. USD | -1,00 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | 7,5 Mio. USD | -1,23 |
| Q3 2024 | 30.09.2024 | 04.11.2025 | 14,3 Mio. USD | -1,17 |
| Q2 2024 | 30.06.2024 | 04.11.2025 | 11,8 Mio. USD | -1,11 |
| Q1 2024 | 31.03.2024 | 04.11.2025 | 7,4 Mio. USD | -1,21 |
| Q3 2023 | 30.09.2023 | 05.11.2024 | 17,2 Mio. USD | -1,22 |
| Q2 2023 | 30.06.2023 | 05.11.2024 | 20,1 Mio. USD | -1,08 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 24.02.2026 | 10-K | 31.12.2025 | 55 Tage | SEC » |
| 04.11.2025 | 10-Q | 30.09.2025 | 35 Tage | SEC » |
| 05.08.2025 | 10-Q | 30.06.2025 | 36 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 25.02.2025 | 10-K | 31.12.2024 | 56 Tage | SEC » |
| 05.11.2024 | 10-Q | 30.09.2024 | 36 Tage | SEC » |
| 06.08.2024 | 10-Q | 30.06.2024 | 37 Tage | SEC » |
| 07.05.2024 | 10-Q | 31.03.2024 | 37 Tage | SEC » |
| 27.02.2024 | 10-K | 31.12.2023 | 58 Tage | SEC » |
| 08.11.2023 | 10-Q | 30.09.2023 | 39 Tage | SEC » |
| 08.08.2023 | 10-Q | 30.06.2023 | 39 Tage | SEC » |
| 10.05.2023 | 10-Q | 31.03.2023 | 40 Tage | SEC » |
| 28.02.2023 | 10-K | 31.12.2022 | 59 Tage | SEC » |
| 07.11.2022 | 10-Q | 30.09.2022 | 38 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 09.05.2022 | 10-Q | 31.03.2022 | 39 Tage | SEC » |
| 28.02.2022 | 10-K | 31.12.2021 | 59 Tage | SEC » |
| 08.11.2021 | 10-Q | 30.09.2021 | 39 Tage | SEC » |
| 10.08.2021 | 10-Q | 30.06.2021 | 41 Tage | SEC » |
| 11.05.2021 | 10-Q | 31.03.2021 | 41 Tage | SEC » |
| 15.03.2021 | 10-K | 31.12.2020 | 74 Tage | SEC » |
| 10.11.2020 | 10-Q | 30.09.2020 | 41 Tage | SEC » |
| 12.08.2020 | 10-Q | 30.06.2020 | 43 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 05.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 08.11.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.01.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-11 | 17 | 32,32 | 549 |
| 2026-05-08 | 21.010 | 31,47 | 661.185 |
| 2026-05-07 | 20 | 32,34 | 647 |
| 2026-04-30 | 28 | 29,38 | 823 |
| 2026-04-29 | 13.405 | 30,56 | 409.657 |
| 2026-04-24 | 2.005 | 30,16 | 60.471 |
| 2026-04-20 | 2.671 | 31,39 | 83.843 |
| 2026-04-17 | 3.138 | 30,33 | 95.176 |
| 2026-04-16 | 12.132 | 30,68 | 372.210 |
| 2026-04-15 | 124 | 30,30 | 3.757 |
| 2026-04-06 | 2.863 | 24,66 | 70.602 |
| 2026-03-30 | 21.273 | 22,19 | 472.048 |
| 2026-03-18 | 45 | 25,83 | 1.162 |
| 2026-03-17 | 5 | 25,49 | 127 |
| 2026-03-10 | 21.697 | 27,62 | 599.271 |
| 2026-03-09 | 6.507 | 26,54 | 172.696 |
| 2026-02-26 | 1.574 | 29,61 | 46.606 |
| 2026-02-12 | 88 | 25,99 | 2.287 |
| 2026-02-06 | 840 | 24,73 | 20.773 |
| 2026-02-05 | 11.989 | 26,95 | 323.104 |
| 2026-02-02 | 153 | 27,62 | 4.226 |
| 2026-01-21 | 1.300 | 30,97 | 40.261 |
| 2026-01-20 | 678 | 31,22 | 21.167 |
| 2025-12-24 | 5.845 | 27,77 | 162.316 |
| 2025-12-23 | 3.435 | 27,92 | 95.905 |
| 2025-12-22 | 39.086 | 26,57 | 1.038.515 |